Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
04/2011
04/27/2011EP2314585A1 Condensed benzamide compounds as inhibitors of vanilloid receptor subtype 1 (VR1) activity
04/27/2011EP2314584A1 2-(heteroaryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
04/27/2011EP2314583A1 Nitrogenated heterocyclic derivative, and agricultural or horticultural bactericidal agent
04/27/2011EP2314582A1 Heterocyclic compounds as antiviral agents
04/27/2011EP2313402A1 Heterocyclic urea derivatives and methods of use thereof
04/27/2011EP2313401A2 Novel discriminating molecule family for neutron and gamma radiation
04/27/2011EP2313400A1 Synthesis of metabolically stable agents for alcohol and drug abuse
04/27/2011EP2313395A1 Pyridone and pyridazone analogues as gpr119 modulators
04/27/2011EP2313393A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof
04/27/2011EP2313391A1 Isoquinolinone derivatives as nk3 antagonists
04/27/2011EP2313380A1 Oxadiazole derivatives for treating diabetes
04/27/2011EP2313370A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
04/27/2011EP2313096A1 New compounds v
04/27/2011EP2313094A1 New pyridine derivatives as leptin receptor modulator mimetics
04/27/2011EP2312949A1 N-heterocyclic m1 receptor positive allosteric modulators
04/27/2011EP2090575B1 Processes and intermediates for the preparation of N4-phenyl-quinazoline-4-amine derivatives
04/27/2011EP2084148B1 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives
04/27/2011EP2055698B1 Chromene compound
04/27/2011EP1735303B1 1,3,4-oxadiazol-2-ones as ppar delta modulators and their use thereof
04/27/2011EP1521746B1 Quinazolinone modulators of nuclear receptors
04/27/2011EP0934307B1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
04/27/2011CN102036982A Substituted pyridin-4-yl-methyl sulfonamides as fungicides
04/27/2011CN102036972A Treatment of duchenne muscular dystrophy
04/27/2011CN102036964A Tetrahydroisoquinolines as antimalarial agents
04/27/2011CN102036955A Hydroxamate-based inhibitors of deacetylases b
04/27/2011CN102030744A Iloperidone crystal and preparation method and medicinal composition thereof
04/27/2011CN102030743A Iloperidone crystal, and preparation method and medicinal composition thereof
04/27/2011CN101550134B Method for preparing 2-[1H-pyrazole-5-radical]-4H-3, 1-benzoxazine-4-ketone compound
04/27/2011CN101370805B Novel pyridine derivatives
04/27/2011CN101180298B New antibiotic derivatives
04/27/2011CN101092415B Compound of new benzo heterocycle categories, preparation method and application
04/26/2011US7932395 Substituted 1H-dihydropyrazoles, their preparation and use
04/26/2011US7932252 CCR9 chemokine receptor modulators; treating inflammatory and immune diseases; inhibit the binding of chemokines, such as TECK (thymus-expressed chemokine), to the CCR9 receptor; 1-arylsulfonamido-2-aryl(alkyl)benzene compounds
04/26/2011US7932250 Thienopyrazole derivative having PDE7 inhibitory activity
04/26/2011US7932247 M3 muscarinic acetylcholine receptor antagonists
04/26/2011CA2634676C Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein cetp
04/26/2011CA2612286C Substituted arylpyrazoles as parasiticidal agents
04/26/2011CA2601458C Benzimidazolone derivatives as cb2 receptor ligands
04/26/2011CA2583742C 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists
04/26/2011CA2508474C Pesticidal sulphonylaminopyrazoles
04/26/2011CA2500952C Neurologically-active compounds
04/26/2011CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use
04/26/2011CA2460145C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
04/26/2011CA2430707C 8-{4-[3-(5-fluoro-1h-indol-3-yl)propyl]-piperazin-1-yl}-2-methyl-4h-benzo[1,4]oxazin-3-one mesylate with high affinity for the dopamine d2 receptor and the serotonin reuptake site
04/21/2011WO2011047390A2 Heterocyclic benzoxazole compositions as inhibitors of hepatitis c virus
04/21/2011WO2011046970A1 Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon
04/21/2011WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses
04/21/2011WO2011046873A1 Hiv integrase inhibitors
04/21/2011WO2011045415A2 New imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
04/21/2011WO2011045292A1 Spiro-condensed cyclohexane derivatives as hsl inhibitors useful for the treatment of diabetes
04/21/2011WO2011045271A1 Herbicidally active, heterocyclyl-substituted pyridazinones
04/21/2011WO2011045270A1 Monohydrate of pardoprunox
04/21/2011WO2011045267A1 Polymorphs of pardoprunox
04/21/2011WO2011045259A1 Aminopropenoates as fungicides
04/21/2011WO2011045240A1 Amides and thioamides as pesticides
04/21/2011WO2011026911A8 Bipyridines useful for the treatment of proliferative diseases
04/21/2011WO2011024192A3 Novel polymorphs of raltegravir
04/21/2011WO2010150281A3 Novel azabicyclohexanes
04/21/2011US20110092700 Novel Coumarin Derivative Having Antitumor Activity
04/21/2011US20110092553 Substituted Azole Derivatives, Compositions, and Methods of Use
04/21/2011US20110092547 Chemical compounds 979
04/21/2011US20110092545 Compounds, Compositions and Methods for Stabilizing Transthyretin and Inhibiting Transthyretin Misfolding
04/21/2011US20110092544 Fungicidal pyridines
04/21/2011US20110092512 New hsl inhibitors useful in the treatment of diabetes
04/21/2011US20110092505 Organic compounds
04/21/2011US20110092504 Inhibitors of pi3 kinase
04/21/2011US20110092503 Quinoline derivatives as axl kinase inhibitors
04/21/2011US20110092501 Novel inhibitors
04/21/2011US20110092491 Compounds and Compositions as Inhibitors of Receptor Tyrosine Kinase Activity
04/21/2011US20110092481 Quinoline or isoquinoline substituted p2x7 antagonists
04/21/2011US20110092480 Substituted Heterocyclic Derivatives and Their Pharmaceutical Use and Compositions
04/21/2011US20110092475 2-substituted-ethynylthiazole derivatives and uses of same
04/21/2011US20110092461 Pyridyl inhibitors of hedgehog signalling
04/21/2011US20110092423 INHIBITORS OF Akt ACTIVITY
04/21/2011US20110092415 Anti-Viral Compounds
04/21/2011CA2777782A1 Sepiapterin reductase inhibitors for the treatment of pain
04/21/2011CA2777762A1 Amino - pyrimidine compounds as inhibitors of tbk1 and/or ikk epsilon
04/21/2011CA2777305A1 Polymorphs of pardoprunox
04/21/2011CA2776457A1 Spiro-condensed cyclohexane derivatives as hsl inhibitors useful for the treatment of diabetes
04/20/2011EP2311831A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands
04/20/2011EP2311830A1 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
04/20/2011EP2311829A1 Substituted alkylamine derivatives and methods of use
04/20/2011EP2311825A1 Pyrimidineamines as angiogenesis modulators
04/20/2011EP2311824A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
04/20/2011EP2311817A1 Isoxazoline Compounds and their Use in Pest Control
04/20/2011EP2311816A1 Isoxazoline Compounds and their Use in Pest Control
04/20/2011EP2311808A1 Substituted alkylamine derivatives and methods of use
04/20/2011EP2311807A1 Compounds and composition as protein kinase inhibitors
04/20/2011EP2311803A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
04/20/2011EP2311802A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
04/20/2011EP2310386A1 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
04/20/2011EP2310385A2 Solid pharmaceutical composition
04/20/2011EP2310384A1 Inhibitors of janus kinases
04/20/2011EP2310381A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer
04/20/2011EP2310378A2 Oxadiazole-2-oxides as antischistosomal agents
04/20/2011EP2310377A1 5-phenyl-isoxazole-3-carboxamides modulating hsp90 with antitumoral activities
04/20/2011EP2310368A1 Small molecule leptin receptor modulators
04/20/2011EP2310359A1 Organic compounds
04/20/2011EP2227466B1 Heteroaryl-substituted piperidines
04/20/2011EP1720872B1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors